布地奈德与博利康尼雾化吸入在小儿呼吸阻塞治疗中的应用效果

The effect of budesonide and boliconi atomization inhalation in the treatment of respiratory obstrouction in children

目的研究布地奈德与博利康尼雾化吸入在小儿呼吸阻塞治疗中的应用效果。方法将我院于2018年7月至2019年7月收治的100例小儿呼吸阻塞患儿作为本次研究对象。对上述患儿采取随机数字表法分为对照组和研究组,其中对照组50例患儿采取布地奈德治疗,研究组50例患儿给予布地奈德与博利康尼雾化吸入治疗,观察2组患儿的治疗效果,比较2组治疗有效率、治疗前后症状体征积分以及不良反应发生率和症状消失时间。结果2组患儿治疗后,其中研究组治疗有效率为96%,对照组治疗有效率为78%。研究组患儿治疗有效率要高于对照组(P<0.05),研究组治疗前的症状体征积分与对照组比较,差异无统计学意义(P>0.05)。治疗后,研究组症状体征积分要优于对照组(P<0.05),研究组患儿不良反应发生率为4%。对照组患儿不良反应发生率为20%。研究组不良反应发生率低于对照组(P<0.05),研究组症状消失时间要短于对照组(P<0.05),其差异有统计学意义。结论对小儿呼吸阻塞患儿予以布地奈德与博利康尼雾化吸入治疗,可显著改善患儿的相关症状,提高治疗效果,并降低不良反应发生率,缩短症状消失时间,该治疗方法值得在临床上推广应用。

Objective To study the effect of nebulized inhalation of budesonide and boliconi in the treatment of respiratory obstruction in children.Methods One hundred children with respiratory obstruction admitted to our hospital from July 2018 to July 2019 were included in this study.Random number table method was used to divide the above-mentioned children into the control group and the research group.Among them,50 patients in the control group were treated with budesonide,and 50 patients in the research group were given budesonide and boliconi inhalation treatment.The treatment effect of the two groups of children was compared for the treatment efficiency,the scores of symptoms and signs before and after treatment,the incidence of adverse reactions and the time of symptom disappearance.Results After the two groups of children were treated,the effective rate of treatment in the study group was 96%.The treatment effective rate of the control group was 78%.The treatment efficiency of the children in the study group was higher than that in the control group(P<0.05).Compared with the control group,the scores of symptoms and signs before treatment in the study group were not statistically significant(P>0.05).After treatment,the scores of symptoms and signs in the study group were better than those in the control group(P<0.05),and the incidence of adverse reactions in the study group was 4%.The incidence of adverse reactions in the control group was 20%.The incidence of adverse reactions in the study group was lower than that in the control group(P<0.05),and the time for symptom disappearance in the study group was shorter than that in the control group(P<0.05).The difference between the two groups was statistically significant.Conclusion Inhalation therapy of budesonide and boliconi is given to children with respiratory obstruction in children.The therapeutic effect is more significant,which can significantly improve the related symptoms of children,improve the treatment effective rate,reduce the incidence of adverse reactions and shorten the time of disappearance of symptoms.This treatment is worthy of clinical application.